Hyperperins A–X, fusicoccane diterpenoids including an unreported 5/7/5/3 tetracyclic carbon skeleton from Hypoestes purpurea and their T-type calcium channel inhibitory activity
IF 7.5 2区 医学Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE
Linfen Ding, Ming Hu, Qiaoling Wei, Shihuan Yin, Xinying Wang, Lu Sai, Wenyan Li, Xingde Wu
{"title":"Hyperperins A–X, fusicoccane diterpenoids including an unreported 5/7/5/3 tetracyclic carbon skeleton from Hypoestes purpurea and their T-type calcium channel inhibitory activity","authors":"Linfen Ding, Ming Hu, Qiaoling Wei, Shihuan Yin, Xinying Wang, Lu Sai, Wenyan Li, Xingde Wu","doi":"10.1016/S1875-5364(26)61219-8","DOIUrl":null,"url":null,"abstract":"<div><div>Two unprecedented rearranged fusicoccane diterpenoids, hyperperins A (<strong>1</strong>) and B (<strong>2</strong>), and twenty-two new fusicoccane diterpenoids, hyperperins C–X (<strong>3–24</strong>), were isolated from the aerial parts of <em>Hypoestes purpurea</em>, as well as one known analog (<strong>25</strong>). The structures and absolute configurations of all newly isolated compounds were determined through comprehensive analyses, including NMR spectroscopy, HR-ESI-MS, electronic circular dichroism calculations, and single-crystal X-ray diffraction analysis. Structurally, compounds <strong>1</strong> and <strong>2</strong> were characterized by a previously unreported carbon skeleton featuring a 5/7/5/3 tetracyclic ring system. Compounds <strong>19</strong> and <strong>20</strong> represent the first examples of fusicoccane diterpenoids with epoxy groups at C-2/C-6 and C-6/C-7, respectively. A plausible biosynthesis pathway for compounds <strong>1</strong> and <strong>2</strong> was proposed. Additionally, compounds <strong>1</strong>, <strong>2</strong>, <strong>3</strong>, <strong>7</strong>, and <strong>25</strong> exhibited potent inhibitory activity against the Ca<sub>v</sub>3.1 calcium channel with IC<sub>50</sub> values of 15.06 ± 1.19, 9.00 ± 1.04, 6.04 ± 0.67, 14.00 ± 1.20, and 6.26 ± 0.82 μmol·L<sup>−</sup><sup>1</sup>, respectively. These findings enrich the structural diversity of fusicoccane diterpenoids and provide promising lead compounds for the development of Ca<sub>v</sub>3.1 calcium channel inhibitors.</div></div>","PeriodicalId":10002,"journal":{"name":"Chinese Journal of Natural Medicines","volume":"24 10","pages":"Pages 1262-1280"},"PeriodicalIF":7.5000,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chinese Journal of Natural Medicines","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1875536426612198","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/9/30 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"INTEGRATIVE & COMPLEMENTARY MEDICINE","Score":null,"Total":0}
引用次数: 0
Abstract
Two unprecedented rearranged fusicoccane diterpenoids, hyperperins A (1) and B (2), and twenty-two new fusicoccane diterpenoids, hyperperins C–X (3–24), were isolated from the aerial parts of Hypoestes purpurea, as well as one known analog (25). The structures and absolute configurations of all newly isolated compounds were determined through comprehensive analyses, including NMR spectroscopy, HR-ESI-MS, electronic circular dichroism calculations, and single-crystal X-ray diffraction analysis. Structurally, compounds 1 and 2 were characterized by a previously unreported carbon skeleton featuring a 5/7/5/3 tetracyclic ring system. Compounds 19 and 20 represent the first examples of fusicoccane diterpenoids with epoxy groups at C-2/C-6 and C-6/C-7, respectively. A plausible biosynthesis pathway for compounds 1 and 2 was proposed. Additionally, compounds 1, 2, 3, 7, and 25 exhibited potent inhibitory activity against the Cav3.1 calcium channel with IC50 values of 15.06 ± 1.19, 9.00 ± 1.04, 6.04 ± 0.67, 14.00 ± 1.20, and 6.26 ± 0.82 μmol·L−1, respectively. These findings enrich the structural diversity of fusicoccane diterpenoids and provide promising lead compounds for the development of Cav3.1 calcium channel inhibitors.
期刊介绍:
The Chinese Journal of Natural Medicines (CJNM), founded and sponsored in May 2003 by China Pharmaceutical University and the Chinese Pharmaceutical Association, is devoted to communication among pharmaceutical and medical scientists interested in the advancement of Traditional Chinese Medicines (TCM). CJNM publishes articles relating to a broad spectrum of bioactive natural products, leading compounds and medicines derived from Traditional Chinese Medicines (TCM).
Topics covered by the journal are: Resources of Traditional Chinese Medicines; Interaction and complexity of prescription; Natural Products Chemistry (including structure modification, semi-and total synthesis, bio-transformation); Pharmacology of natural products and prescription (including pharmacokinetics and toxicology); Pharmaceutics and Analytical Methods of natural products.